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Abstract. 
 
In the central nervous system, myelination
of axons occurs when oligodendrocyte progenitors
undergo terminal differentiation and initiate process 
formation and axonal ensheathment. Although it is hy-
pothesized that neuron-oligodendrocyte contact ini-
tiates this process, the molecular signals are not known. 
Here we ﬁnd that Fyn tyrosine kinase activity is upreg-
ulated very early during oligodendrocyte progenitor 
 
cell differentiation. Concomitant with this increase is 
the appearance of several tyrosine phosphorylated pro-
teins present only in differentiated cells. The increased 
tyrosine kinase activity is speciﬁc to Fyn, as other Src 
family members are not active in oligodendrocytes. To 
investigate the function of Fyn activation on differenti-
ation, we used Src family tyrosine kinase inhibitors, PP1 
and PP2, in cultures of differentiating oligodendrocyte 
progenitors. Treatment of progenitors with these com-
pounds prevented activation of Fyn and reduced pro-
cess extension and myelin membrane formation. This 
inhibition was reversible and not observed with related 
inactive analogues. A similar effect was observed when 
a dominant negative Fyn was introduced in progenitor 
cells. These ﬁndings strongly suggest that activation of 
Fyn is an essential signaling component for the mor-
phological differentiation of oligodendrocytes.
Key words: oligodendrocyte • myelin • Fyn • differ-
entiation • tyrosine phosphorylation
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LIGODENDROCYTES
 
 are the myelin-forming cells of
the central nervous system. Early oligodendrocyte
progenitors arise from neuroepithelium in the
ventral spinal cord and migrate throughout the brain pa-
renchyma (Levison et al., 1993; Price 1994). Upon termi-
nal differentiation, oligodendrocytes extend several pro-
cesses that ensheathe and myelinate nerve axons. In vitro,
mature oligodendrocytes extend a complex network of
processes, and extensive myelin-like membrane sheets in
the absence of axons (Dyer and Benjamins, 1988). Differ-
entiation of progenitors into the mature phenotype is
characterized by both morphological changes and the ap-
 
pearance of stage-specific cell surface markers (Pfeiffer et al.,
1993), but the signals that trigger this program, both in
vitro and in vivo, are not known.
Fyn is a member of the Src family of cytoplasmic nonre-
ceptor tyrosine kinases (reviewed by Thomas and Brugge,
1997). There are nine members of this family, some of
which (Src, Lyn, and Fyn) are widely expressed in many
tissues, and others which are more restricted in their ex-
pression. These protein kinases can be activated by a vari-
 
ety of extracellular signals, and interact with multiple
intracellular substrates, including focal adhesion kinase
 
(FAK)
 
1
 
, p130Cas, structural proteins such as cortactin,
and connexin 43, and stimulate other signaling pathways
within the cell. Src family kinases have been linked to cel-
lular events such as cell adhesion, cytoskeletal rearrange-
ments, cell migration, regulation of the cell cycle, apopto-
sis, and differentiation (Boschek et al., 1981; Hecker et al.,
1991; Twamley-Stein et al., 1993; Kaplan et al., 1995; Ro-
dier et al., 1995; Huang et al., 1997).
Several lines of evidence suggest that Fyn has a role in
myelination. Fyn is expressed at high levels in the brain
and is localized to neurons and glial cells (Umemori et al.,
1992; Bare et al., 1993). The myelin content in brains from
 
fyn
 
-deficient transgenic mice is significantly reduced, as
demonstrated by Western analysis of myelin basic protein
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(MBP) and by immunohistochemical analysis of MBP ex-
pression in brain sections (Umemori et al., 1994). Fyn can
also be coimmunoprecipitated from brain lysates with
antibodies to myelin-associated glycoprotein (MAG) (Ume-
mori et al., 1994). Since MAG is one of the earliest myelin
proteins to be expressed, these findings suggest that Fyn is
involved in the myelination process. However, the precise
role of Fyn in oligodendrocytes and the myelination pro-
cess has not yet been defined. This study reveals that acti-
vation of Fyn is one of the earliest events triggered as oli-
godendrocyte progenitor cells differentiate, and that Fyn
tyrosine kinase regulates process extension and myelin
sheet formation in vitro.
 
Materials and Methods
 
Cell Culture
 
Primary cultures of oligodendrocyte progenitor cells were isolated from
P2 neonatal rat brain (Sprague Dawley; Taconic Farms) according to the
procedure of Osterhout et al. (1997) with slight modifications. In brief,
mixed dissociated cultures of neonatal brain were allowed to reach conflu-
ence, after which the oligodendrocyte progenitor population was removed
by shaking. The progenitor cells were further purified by immunopanning
with A2B5 (Osterhout et al., 1997), and plated onto polylysine (PLL)-
coated dishes. Progenitors were lysed 24 h after plating and analyzed for
Fyn protein expression and kinase activity (see below). Differentiation of
progenitor cells was initiated by switching the media to a defined media
lacking growth factors (Osterhout et al., 1997). To maintain the cells as
progenitors, and prevent differentiation, PDGF and FGF were included in
the differentiation media at concentrations that stimulate the maximal
proliferation of the cells (10 ng/ml and 20 ng/ml, respectively; Osterhout
et al., 1997). The mature oligodendrocytes were analyzed for Fyn expres-
sion and activity after 4–6 d in culture. The differentiation state of the
cells, either progenitor or mature oligodendrocyte, was determined by im-
munocytochemical analysis of stage-specific markers such as A2B5 for
progenitor cells, and O1, MAG, and MBP for differentiated oligodendro-
cytes (Pfeiffer et al., 1993). For the inhibitor studies, PP1, PP2, PP3, and
PP4 (Calbiochem Novabiochem) were resuspended in DMSO, and in-
cluded in the culture media at specified concentrations.
 
Immunocytochemistry and Morphological Analysis
 
Cells were grown on PLL-coated 10-mm glass coverslips (Dynalab) for all
immunochemistry. For oligodendrocyte lineage markers such as A2B5
and O1, the coverslips were rinsed in PBS (10 mM sodium phosphate, pH
7.2, 150 mM NaCl) and incubated in antibody diluted in PBS for 30 min at
room temperature (RT). The coverslips were then fixed in 4% parafor-
maldehyde for 30 min. For Fyn localization, the cells were permeabilized
with 0.2% Triton X-100, then incubated with a rabbit antibody to Fyn
(Santa Cruz Biotechnology) overnight at 4
 
8
 
C. Fluorescein- and rho-
damine-conjugated secondary antibodies (Vector Labs) were diluted 1:50
in PBS and left on the coverslips for 30 min. For each immunostain, one
coverslip was incubated in the secondary antibody alone as a negative
control for background immunofluorescence. The coverslips were rinsed
in PBS and mounted on glass slides using Vectashield (Vector Labs). In
all staining procedures, labeled cells were visualized using a Nikon Op-
tiphot microscope or a Leica confocal microscope.
For analysis of process outgrowth, the distance from the center of the
cell body to the tip of the longest process was measured, which in mature
oligodendrocytes corresponds to the radius of the extensive process net-
work that surrounds the cell body. For PP1-inhibited cells, this corre-
sponds to the length of the longest process extending from the cell. If a
process was not longer than the cell body diameter, it was not measured.
For each condition, process outgrowth was measured for 200 individual
cells from control and inhibitor-treated cells.
 
Immunoprecipitation, In Vitro Kinase Assays, and 
Western Blotting
 
Cells were washed twice with cold STE (100 mM NaCl, 10 mM Tris, pH
 
7.4, 1 mM EDTA) and lysed in 1 ml of NP-40 lysis buffer (20 mM Tris, pH
8.0, 150 mM NaCl, 1% Nonidet P-40, 2.5 mM EDTA, 10 mM NaF, 1 mM
Na
 
3
 
VO
 
4
 
, 10 
 
m
 
g/ml aprotonin, 10 
 
m
 
g/ml leupeptin, 1 mM PMSF). Cell ly-
sates were then processed for immunoprecipitation as described (Wolven
et al., 1997). In vitro kinase assays, enolase phosphorylation assays, and
Western blotting have been described previously (Wan et al., 1997; Wol-
ven et al., 1997). Quantitation of band intensity in both the Western anal-
ysis and kinase assays was accomplished using a Molecular Dynamics
PhosphorImager.
 
Antibodies
 
Antibodies raised against amino acids 1–148 of Fyn for immunoprecipita-
tion have been previously described (Wolven et al., 1997). Rabbit poly-
clonal antibodies to Src, Fyn, Lck, and Lyn were purchased from Santa
Cruz Biotechnology. Antiphosphotyrosine antibodies 4G10 and PY20
were purchased from UBI and Transduction Labs. MAG antibodies were
a generous gift from Dr. Marie Filbin (Hunter College, New York). O1
antibodies were a generous gift from Drs. Steven Pfeiffer and Rashmi
Bansal (University of Connecticut, Farmington, CT). Antibodies to neo-
mycin phosphotransferase II (NPTII) were purchased from 5
 
9
 
®
 
3
 
9
 
.
 
Cellular Expression of a Dominant Negative Fyn
 
The K299M Fyn construct contains a point mutation in the ATP binding
pocket (lysine 299 was changed to methionine), rendering the kinase inac-
tive (Twamley-Stein et al., 1993). The K299M Fyn cDNA was generated
in SP65 using wild-type Fyn as a substrate, and subsequently cloned into
the retroviral pLJ vector (Wolven et al., 1997). The mutation was verified
by DNA sequencing. 
 
c
 
2 cells were transfected with K299M or pLJ plas-
mids, and cell supernatants containing the retrovirus were collected and
used to infect oligodendrocyte progenitor cultures.
 
Results
 
Intracellular Localization of Fyn
 
Primary cultures of oligodendrocyte progenitors typically
contain bipolar cells that are characterized by the expres-
sion of the surface markers A2B5 (80–90%) and O4 (10–
20%). These progenitors can be induced to differentiate
by switching to a serum-free differentiation media 24 h af-
ter plating (see Materials and Methods). After several
days in culture, mature cells are characterized by marked
process outgrowth, with an increase in the number of pro-
cesses emanating from the cell body and extensive branch-
ing of these processes. The result is an intricate lacework
of processes that surrounds the oligodendrocyte cell body.
The morphological changes are accompanied by the ap-
pearance of the cell surface galactocerebroside O1, as well
as myelin proteins such as MAG and MBP. At later stages,
the extensive process outgrowth gives rise to the forma-
tion of myelin-like membrane sheets, which can be visual-
ized by staining for O1 (Sommer and Schachner, 1981).
Fyn is expressed in both the progenitors and differentiated
cell populations (Figs. 1 and 2, immunocytochemistry and
Western analysis, respectively). In progenitors, Fyn is lo-
calized primarily to the cell body and found along the
length of the processes. (Fig. 1 A). Likewise in the mature
oligodendroycte, Fyn is observed in the cell body and
throughout the processes (Fig. 1 B). Staining for O1 and
Fyn also confirmed that the majority of Fyn immunoreac-
tivity can be visualized in the cell body and processes of
the mature cell (Fig. 1 C).
 
Fyn Upregulation in Oligodendrocytes
 
To investigate whether Fyn protein levels changed during 
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differentiation, Western analysis of oligodendrocyte cell
populations was performed. The bipolar progenitors were
harvested 24 h after plating. Mature oligodendrocytes
were harvested after allowing progenitors to differentiate
for 5–6 d. Fyn protein is expressed at levels two- to three-
fold higher in the mature cells compared with progenitors
(Fig. 2 A). Moreover, Fyn tyrosine kinase activity in ma-
ture oligodendrocytes is 10–30-fold higher than that of the
progenitors (Fig. 2, B, D, and E), as measured by autoki-
nase activity and enolase phosphorylation. This suggests
that the specific activity of Fyn is increased 3–15-fold per
unit of Fyn protein in the mature cells. Since oligodendro-
cyte differentiation occurs over 5–6 d in vitro, Fyn activity
was examined each day after the plating of oligodendro-
cyte progenitors to establish the time course of Fyn upreg-
ulation during differentiation. Fyn autokinase activity was
used as an indication of Fyn activation, as it mimics the re-
sults obtained by measuring enolase phosphorylation (Fig.
2, D and E). The observed increase in Fyn activity occurs
within 24 h after switching to differentiation media, which
corresponds to 48 h after plating (Fig. 2 C). Remarkably,
cells at this time point are indistinguishable from those
progenitors harvested at 24 h after plating, both in mor-
phology and in the expression of stage specific markers.
Since Fyn activation precedes any morphological changes
that accompany differentiation, these observations suggest
that the upregulation of Fyn is a very early event in the
maturation of oligodendrocyte progenitors.
Several members of the Src family of tyrosine kinases
are expressed in the neonatal brain, including Src, Fyn,
Lyn, and Yes (Fig. 2 A, lanes denoted T). However, analy-
sis of oligodendrocyte cell lysates (Fig. 2, D and E) re-
vealed that Fyn is the only member of the Src family with
significant kinase activity in either cultured oligodendro-
cytes or progenitor cells. Src is not expressed or catalyti-
cally active in these cells; Yes protein is barely detectable
in differentiated cells, but is not active (Fig. 2, A, D, and
E). Lyn protein is expressed in both the progenitors and
Figure 1. Fyn localization in oligodendrocytes. (A) Primary cultures of oligodendrocyte progenitors contain simple bipolar cells, which
are A2B5 positive (rhodamine fluorescence). Fyn (fluorescein fluorescence) is localized to the cell body and processes. (B) After 4 d in
culture, oligodendrocytes show extensive process outgrowth, a characteristic of differentiation. Fyn is localized to the cell body and
throughout the processes (fluorescein fluorescence). (C) At later stages of differentiation, oligodendrocytes will extend large myelin-
like membrane sheets in culture, which can be visualized by immunostaining for the galactocerebroside O1 (rhodamine fluorescence).
Fyn (fluorescein fluorescence) is expressed at high levels in the cell body, and can also be seen in small veins throughout the myelin
sheet. Bars: (A–C) 20 mm. 
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mature oligodendrocytes (Fig. 2 A), but Lyn tyrosine ki-
nase activity was not detected in either population of cells
(Fig. 2, D and E). Analysis of kinase activity was per-
formed using two different substrates, including autoki-
nase as well as enolase phosphorylation for all Src family
members (Fig. 2, D and E). These findings distinguish oli-
godendrocytes as one of the few cell systems in which Fyn
is the major active Src family member. These cells there-
 
fore can provide a useful system in which to study Fyn
function.
 
Lack of Growth Factor Modulation of Fyn
 
Growth factors such as PDGF and FGF stimulate progeni-
tor cell proliferation, regulate cell migration and modulate
differentiation in the oligodendrocyte lineage (Noble et al.,
1988; Besnard et al., 1989; Osterhout et al., 1997). In vitro,
progenitors maintained in the presence of these growth
factors fail to differentiate; withdrawal from the cell cycle
and terminal maturation is triggered by removal of the
growth factors. In the protocol used for this study, progen-
itors are harvested soon after plating; under these condi-
tions, the progenitors have a low basal level of Fyn kinase
activity (Fig. 2, D and E). Since PDGF and FGF can acti-
vate Src and Fyn in other cell types (Twamley-Stein et al.,
1993; Langren et al., 1995), we examined the possibility
that PDGF and FGF are required to activate Fyn in the
progenitor cell population. Fyn kinase activity was exam-
ined after acute treatment with FGF (20 ng/ml) and PDGF
(10 ng/ml) for 5, 10, and 20 min. There was no increase in
Fyn activity above basal levels (Fig. 3, A and B). Since dif-
ferentiation can be prevented by maintaining progenitors
in the presence of growth factors (McKinnon et al., 1990),
we also examined the effects of chronic treatment with
growth factors. After 3 d in culture with either PDGF (10
ng/ml) or
 
 
 
FGF (20 ng/ml), Fyn activity remained at basal
levels (Fig. 3, A and B). Fyn activity
 
 
 
was not upregulated
until the growth factors were withdrawn, which triggered
differentiation.
It is also possible that the increase in Fyn activity could
be influenced by specific media components. Fyn kinase
activity was assayed in cells cultured under several differ-
ent media formulations, each of which will allow oligo-
dendrocyte differentiation, but vary in their composition
(Barres et al., 1993; Osterhout et al., 1997; Yoon et al.,
Figure 2. Fyn is the only Src family member upregulated during
oligodendrocyte differentiation. (A) Western blot of Fyn and
other Src family members immunoprecipitated from progenitor
cells (P) or differentiated oligodendrocytes (D). As a control,
equal amounts of total brain lysate (T) were analyzed in parallel
for protein expression. (B) In vitro autokinase assay of Fyn in
progenitor cells (P) and differentiated oligodendrocytes (D).
Two independent cell preparations were used for these experi-
ments. (C) Activation of Fyn occurs very early during oligoden-
drocyte differentiation. Fyn autokinase activity was assayed ev-
ery day after plating (lanes 1–5); the upregulation is observed 2 d
after plating (lane 2), which is 24 h after introducing media to ini-
tiate differentiation (see Materials and Methods). Lane 1 corre-
sponds to progenitor cells, harvested 24 h after plating. (D) Spec-
ificity of the Src family member tyrosine kinase activity in
oligodendrocytes. Fyn, Src, Yes, Lck, and Lyn were immunopre-
cipitated from equal amounts of cell lysates (100 mg protein)
from progenitor cells (P) or differentiated oligodendrocytes (D)
and autokinase assays were performed. (E) Fyn is the only Src
family kinase active in oligodendrocytes. Src, Fyn, Yes, or Lyn
were immunoprecipitated from equal amounts of cell lysate (100
mg protein) and both autokinase and enolase phosphorylation
was measured. Note that Fyn kinase activity is significantly in-
creased as compared with other Src kinases in both the autoki-
nase and enolase phosphorylation.
Figure 3. Lack of growth fac-
tor stimulation of Fyn kinase
activity. Progenitors cells
were treated with either FGF
(A) or PDGF (B) for various
times, then harvested and as-
sayed for Fyn kinase activity.
Neither growth factor could
elicit an increase in activity,
after acute or chronic treat-
ments. The only increase in
Fyn tyrosine kinase activity
was measured after progeni-
tors were induced to differ-
entiate by withdrawing the
growth factors. 
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1998). There were no differences in the levels of Fyn ki-
nase activity in the mature oligodendrocytes under these
different culture conditions (data not shown). These data
indicate that the activation of Fyn is closely associated
with the start of progenitor cell differentiation and not
stimulated by FGF or PDGF. The lack of growth factor
regulation suggests that activation of Fyn in oligodendro-
cytes is achieved via a novel regulatory mechanism, which
is an early event in the terminal differentiation of oligo-
dendrocytes.
 
Protein Phosphorylation in Oligodendrocytes
 
The upregulation of Fyn kinase activity during differentia-
tion suggests that enhanced tyrosine phosphorylation of
potential Fyn substrates should be evident in mature oli-
godendrocytes. This supposition was verified by the results
depicted in Fig. 4 A, in which an increase in tyrosine phos-
phorylated proteins was observed in both total cell lysates
and Fyn immunoprecipitates of differentiated cells. Sev-
eral proteins were phosphorylated and associated with
Fyn as oligodendrocytes differentiate, and these phos-
phorylated proteins were also observed in Fyn autokinase
assays on oligodendrocyte lysates (Fig. 2, C and D). These
proteins were not phosphorylated under the assay condi-
tions required for enolase phosphorylation by Fyn (Fig. 2
E). Interestingly, these proteins were not phosphorylated
in autokinase assays using progenitor cell lysates even
though there is a low level of Fyn activity, which suggests
that phosphorylation of these proteins is part of the matu-
ration program. These phosphorylated bands appear to be
novel and specific to oligodendrocytes. They do not corre-
spond to any known Src or Fyn substrates, including Fak,
Cbl, p130Cas, annexins, PI3 kinase, or cortactin, and the
identification of these potentially novel proteins is cur-
rently under investigation.
 
Inhibition of Fyn Activity and
Oligodendrocyte Differentiation
 
To determine whether activation of Fyn was required for
differentiation, we examined the fate of progenitors cul-
tured in the presence of the tyrosine kinase inhibitors PP1
and PP2. These pyrazolopyrimidine derivatives are potent
and specific inhibitors of Src family kinases in T cells and
compete with ATP to prevent phosphorylation (Hanke et al.,
1996). They have different affinities for each member and
do not inhibit other tyrosine kinases at the concentrations
effective for the Src kinase family (Hanke et al., 1996).
Since Fyn is the only Src family kinase active in this cell
system, Fyn should be the only Src family member af-
fected by the inhibitors. Fyn kinase activity in lysates from
mature oligodendrocytes was significantly lower in the
presence of PP1 and PP2 (Fig. 4 B), and a corresponding
reduction in tyrosine phosphorylation of total cellular pro-
tein was observed (Fig. 4 C). Inhibition of Fyn kinase ac-
tivity by PP1 was concentration dependent, with total inhi-
bition occurring at concentrations of 5 
 
m
 
M and higher. The
effects of PP1 are specific since the inactive compound
PP3 could not inhibit Fyn kinase (Hanke et al., 1996). The
activity levels of Fyn in oligodendrocytes in the presence
of PP3 were comparable to control cells (Fig. 4 B). Ty-
rosine phosphorylation of proteins in the total cell lysates
Figure 4. Tyrosine phosphorylation in oligodendrocytes. (A) Im-
munoblots show an increase in tyrosine phosphorylation in total
cell lysates from differentiated (D) oligodendrocytes as com-
pared with progenitors (P). Fyn immunoprecipitates reveal sev-
eral phosphorylated proteins that are associated with Fyn in the
differentiated (D) oligodendrocytes but not in the progenitors
(P). (B) PP1 and PP2 will inhibit Fyn kinase activity in a dose-
dependent manner. Fyn kinase assays on lysates from mature oli-
godendrocytes were performed in the presence of 0.1, 1, 5, and
10 mM PP1 and PP2. Fyn activity is significantly reduced at 1 mM
compared with control (C); no activity is observed at 5 and 10 mM
of either compound. PP3, an inactive analogue, has no effect on
Fyn kinase activity. (C) Tyrosine phosphorylation in total cell ly-
sates is reduced, but not abolished, in differentiated oligodendro-
cytes treated with increasing concentrations of PP1. Fyn auto-
phosphorylation is reduced by 10% at 0.1 mM PP1, and 70% at
5 mM PP1. The bands at 100–120, 85–90, and 40 kD (arrows) are
speculated to be Fyn substrates; their phosphorylation is also sig-
nificantly reduced in the presence of PP1. 
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was reduced but not eliminated in the presence of PP1
(Fig. 4 C). At low concentrations, where PP1 has limited
effects on Fyn activity (Fig. 4 B), there was a slight reduc-
tion in tyrosine phosphorylation, including Fyn autophos-
phorylation. As the concentration of PP1 increased, the
levels of tyrosine phosphorylation measurably decreased.
Fyn autophosphorylation was reduced by 70% at 5 
 
m
 
M
PP1 (Fig. 4 C), a concentration at which Fyn kinase activ-
ity is totally inhibited (Fig. 4 B). Similar reductions in ty-
rosine phosphorylation were observed in immunoblots
probed with anti-phosphotyrosine antibodies, including
proteins at 100–120, 80–85, and 40–45 kD, which may rep-
resent Fyn substrates in oligodendrocytes. The observa-
tion that tyrosine phosphorylation was not totally elimi-
nated in the presence of PP1 suggests that while Fyn is an
important kinase in these cells, other tyrosine kinases may
be active and not inhibited by the PP1 inhibitor family.
One possibility is Csk, which phosphorylates Fyn at ty-
rosine 527 and acts as a negative regulator of Fyn (Chow
et al., 1993).
If activation of Fyn tyrosine kinase is indeed responsible
for differentiation, then treatment of cells with PP1 should
block this process. Progenitors induced to differentiate in
the presence of PP1 retracted their processes and clumped
together in the dish (Fig. 5). This retraction was evident af-
ter 1–2 d in differentiation media, just as the control cells
started to extend multiple processes. This effect was dose
dependent; at low concentrations (1 
 
m
 
M), there was a 10%
reduction in process outgrowth after 4 d, as assessed by
measuring the radius of the extensive process network
that surrounds the oligodendrocyte cell body. At concen-
trations 
 
,
 
1 
 
m
 
M, there were no observable effects on
cell morphology (data not shown). In the presence of 5
 
m
 
M PP1, process outgrowth was significantly inhibited
(
 
.
 
95%). All of the cells extended only one or two short,
unbranched processes which were generally less that one
cell body diameter in length. The treated cells lacked the
extensive process network that is characteristic of the dif-
ferentiated phenotype, and morphologically resembled
oligodendrocyte progenitor cells. None of the cells formed
the myelin-like membrane sheets observed in cultures of
mature oligodendrocytes. The degree of process retraction
observed with increasing concentrations of the inhibitors
can be correlated with the levels of Fyn kinase inhibition
observed in the in vitro kinase assays (Fig. 4 B), which sug-
gests that Fyn kinase activity is required for process exten-
sion during oligodendrocyte differentiation.
While the inhibition of Fyn activity clearly retarded pro-
cess outgrowth, it did not affect the expression of the cell
surface marker galactocerebroside O1 (Fig. 5, B, D, F, and
H) and myelin proteins MAG and myelin basic protein
 
Figure 5.
 
Effect of PP1, a Fyn tyrosine kinase inhibitor, on oligo-
dendrocyte differentiation. (A and B) Oligodendrocyte progeni-
tor cells differentiate into the mature phenotype after 4–6 d in
vitro. Phase contrast (A) of live oligodendrocyte cultures 6 d af-
ter plating. The differentiating cells extend a complex network of
branched processes. O1 immunostaining of sister cultures (B) re-
veal the myelin-like membrane sheets that are formed in the later
stages of oligodendrocyte differentiation, which are not visible
under phase contrast optics. (C and D) PP1 inhibits process out-
growth and membrane sheet formation in a dose-dependent man-
ner. Phase contrast (C) of oligodendrocyte progenitor cells in-
duced to differentiate in the presence of 1 mM PP1 for 4 d. Some
cells in culture with 1 mM PP1 show a slight inhibition of process
outgrowth; O1 expression is not affected (D). (E and F) At
higher concentrations of PP1 where Fyn kinase activity is totally
abolished (5 mM; see Fig. 4 B), process outgrowth is significantly
inhibited after 3–4 d in culture. Few cells extend short processes,
and the cell bodies have rounded up and clumped together (E).
However, these cells do express cell surface markers characteris-
tic of mature oligodendrocytes, including O1 (F). (G and H) PP3
has no effect on oligodendrocyte differentiation. Oligodendro-
cyte progenitors will fully differentiate in the presence of PP3,
which does not inhibit Fyn kinase activity (G; see Fig. 4 B). Phase
contrast of differentiating oligodendrocytes 4 d after plating.
Note the extensive process outgrowth evident at this timepoint.
These cells have not yet reached the stage where they form my-
elin-like membrane sheets, but they do express markers charac-
teristic of mature cells, including O1 (F). 
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(Fig. 6). The process retraction was reversible, as removal
of PP1 resulted in renewed process extension as early as 24 h
after the inhibitor removal (Fig. 7, A and B). To control
for any non-specific effects, cells were treated with the re-
lated inactive analogues PP3 and PP4, which had no effect
on Fyn activity (Fig. 4 B) and no effect on differentiating
cells in culture (Fig. 5 G). Finally, when progenitors were
maintained in FGF and PDGF, mitogens that block differ-
entiation (Noble et al., 1988; Bogler et al., 1990; McKin-
non et al., 1990), PP1 had no effect on process outgrowth
or cell division (Fig. 7, C and D). Progenitor cells main-
tained in 10 
 
m
 
M PP1, a concentration that completely in-
hibits Fyn kinase activity (Fig. 4 B) proliferated normally
in the presence of FGF and PDGF, and maintained a bipo-
lar morphology. These data suggest that the PP1 family of
inhibitors are not toxic to the cells, but are acting solely to
inhibit Fyn kinase activity. Thus, inhibition of Fyn activity
appears to block morphological differentiation of progeni-
tors into mature oligodendrocytes, without affecting the
synthesis of stage-specific proteins that are characteristi-
cally expressed by mature oligodendrocytes.
To verify the requirement for Fyn in oligodendrocyte
differentiation, a kinase inactive, dominant negative Fyn
was introduced into cultures of differentiating oligoden-
drocyte progenitors. The construct contains a point muta-
tion in the ATP-binding site in which lysine 299 was mu-
tated to methionine (Fig. 8 A). This mutation results in a
Fyn protein that cannot bind ATP and is catalytically inac-
tive (Twamley et al., 1992; Twamley-Stein et al., 1993).
The Fyn K299M mutant can still bind to substrate mole-
cules and acts in a dominant negative fashion when ex-
pressed with wild-type Fyn in cells (Twamley et al., 1992).
Figure 6. Expression of myelin pro-
teins in oligodendrocytes. (A and
B) MBP expression in differentiat-
ing oligodendrocytes (A) and in oli-
godendrocytes maintained the pres-
ence of 5 mM PP1 for 4 d (B). (C
and D) MAG expression in mature
oligodendrocytes (C) and in cells
differentiating in the presence of 5
mM PP1 (D). Note that in the pres-
ence of PP1, myelin proteins are
still expressed, despite the lack of
processes or myelin-like membrane
sheets.
Figure 7. The effects of PP1 are reversible. (A and B) Progeni-
tors differentiated in the presence of 5 mM PP1 show little pro-
cess outgrowth after 3 d (A); 24 h after removal of PP1, the cells
have renewed the extensive process outgrowth characteristic of
the mature oligodendrocyte (B). PP1 has no effect on non-differ-
entiated progenitors. (C and D) Oligodendrocyte progenitors
were maintained in FGF and PDGF (20 and 10 ng/ml, respec-
tively) and 10 mM PP1 for 4 d; in contrast to the differentiating
cultures, PP1 had no effect on process outgrowth after 1 d (C) or
4 d (D) of treatment. The rate of cell proliferation was identical
in control and PP1-treated cells. Bar, 6 mm. 
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The Fyn K299M cDNA was inserted into the viral pLJ
vector containing an IRES sequence linked to the Neo
gene, which confers resistance to geneticin, and allows for
both selection and immunocytochemical detection of cells
infected with the recombinant retrovirus (Fig. 8).
Oligodendrocyte progenitors were infected with a vec-
tor control or Fyn kinase inactive vector using the protocol
of Wolven et al. (1997) and maintained in differentiation
media. Infected cells were detected by immunostaining for
neomycin phosphotransferase II (NPTII). Attempts to se-
lect for stable cell lines expressing the construct failed,
even in low concentrations of G418. However, in transient
infections, many cells were positive for NPTII, although
the levels of staining varied considerably. Several effects
were evident in the cultures infected with the Fyn K299M
vector (Fig. 8, B and D). Cells infected with the pLJ vec-
tor alone proceeded to differentiate normally, extending
branched processes after culture in differentiation media
(Fig. 8, A and C). Cultures infected with the inactive Fyn
kinase construct showed considerable inhibition of process
outgrowth after 3 d (Fig. 8, B and D). During the time
course allowed for differentiation, many cells rounded up
and detached from the plate, and it is not known whether
these cells were expressing the mutant Fyn protein. Others
extended processes less than one cell diameter in length
and resembled those cells treated with the PP1 inhibitors.
A few NPTII positive cells extended processes similar to
 
the vector control. Overall, there was a 50% reduction
(Fig. 8 E) in the number of cell extending processes longer
than one cell body in diameter in the cells expressing the
Fyn K299M virus compared with control. Since these data
are derived from transient infections in which only 10–
30% of the cells were infected, it was not feasible to assay
the level of Fyn kinase activity in the cells expressing the
mutant construct. However, the reduction in process out-
growth observed in cultures expressing the dominant neg-
ative Fyn supports the hypothesis that Fyn kinase activa-
tion is required for the formation of processes that occurs
during oligodendrocyte differentiation.
 
Discussion
 
The initial observation that Fyn-deficient mice showed re-
duced myelination in the central nervous system suggested
that this tyrosine kinase could be one of the signals in-
volved in regulating myelination during development
(Umemori et al., 1994). However, the underlying mecha-
nism for the failure to myelinate in these mice was un-
clear. The present study directly examines the potential
role of Fyn in myelination using primary cultures of differ-
entiating oligodendrocytes. This is a well-characterized
cell system; differentiation proceeds along a defined path-
way, marked by discrete stages that can be identified by
both morphological changes and the expression of cell sur-
Figure 8. The expression of a kinase in-
active Fyn in differentiating oligodendro-
cyte progenitors inhibits process out-
growth. Progenitors infected with the pLJ
vector (A and C) will differentiate nor-
mally, extending a network of processes.
In contrast, many of the cells infected
with the kinase inactive K299M Fyn have
lifted off the plate after 3 d in culture (B
and D). Of the remaining cells, while
some cells extend processes, many others
have failed to do so. At higher magnifica-
tion, the lack of processes is more evi-
dent. After 3 d in differentiation media,
cells expressing the pLJ vector have ex-
tended multiple, highly branched processes (C). In contrast, many of the cells expressing K299M Fyn lack processes longer than one cell
body; a few short processes can be observed, but they never elongate (D; arrow). This data is quantitated above; the number of infected
cells extending processes longer than one cell body in length is reduced by 50% in the cell expressing the kinase inactive Fyn. The data
is summarized from three individual transient infections, with an infection rate of 10–30% per culture. Bar, 20 mM. 
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face markers and myelin proteins (Pfeiffer et al., 1993).
Our results indicate that Fyn tyrosine kinase is activated
very early after the oligodendrocyte progenitor cells are
induced to differentiate (Fig. 2). This upregulation occurs
at a point before the appearance of MAG in these cells, in-
dicating that another signal triggers Fyn in these cells. In-
hibition of the kinase activity during differentiation pre-
vents the extensive process outgrowth and formation of
membrane sheets normally observed in cultures of mature
oligodendrocytes, suggesting that Fyn may regulate cy-
toskeletal rearrangements that control process extension.
The observed increase in Fyn activity is triggered as pro-
genitor cells are induced to differentiate by maintaining
them in a defined differentiation media. Activation of Src
family kinases in other cell types is commonly triggered by
external signals, such as growth factor–receptor binding,
or integrin-substrate interactions (reviewed by Thomas
and Brugge, 1997). Since cells in the oligodendrocyte lin-
eage are responsive to growth factors, it was surprising
that Fyn activation was not affected by growth factor
treatment. This finding suggests that another external sig-
nal or a novel regulatory mechanism is responsible for Fyn
activation. Oligodendrocytes do express integrins on their
cell surface that can modulate migration of these cells
(Milner et al., 1996, 1997); however it is unlikely that inte-
grins are responsible for this response, as there are no
abrupt changes in cell adhesion or extracellular substrates
when Fyn is activated. Thus, it is likely that a novel regula-
tory mechanism is responsible for this activation, poten-
tially involving release of a negative regulatory mechanism
when the cells are placed in media lacking mitogens. It is
possible that Csk, a negative regulator of Fyn, may be
highly active in oligodendrocyte progenitors treated with
growth factors; thus Fyn activity would be low until the
growth factors are removed and Csk is downregulated. Al-
ternatively, the withdrawal of growth factors causes the
progenitors to exit the cell cycle and begin to differentiate
(Casaccia-Bonnefil et al., 1997; Durand et al., 1997). Signal
transduction pathways that modulate differentiation may
be activated once the cells leave the cell cycle, resulting in
subsequent activation of Fyn. Elucidation of the upstream
signal that triggers Fyn activation may ultimately reveal
the specific cellular pathways involved in oligodendrocyte
differentiation.
Since Fyn is the primary Src family kinase activated dur-
ing oligodendrocyte differentiation, these cells provide a
model system in which to study biological effects of Fyn
activation. The inhibition of Fyn, by either a pharmacolog-
ical inhibitor or by expression of a dominant negative Fyn
protein, suggests that Fyn can regulate the cytoskeletal re-
arrangements that accompany oligodendrocyte differenti-
ation. The localization of Fyn to processes further sup-
ports this hypothesis. The precise mechanism underlying
this effect is unknown at present; while it is clear that sev-
eral proteins are phosphorylated when Fyn is activated in
these cells, the identity of these proteins is unknown. It is
not clear that phosphorylation of any one specific protein
is the critical event that modulates the observed process
retraction. Examination of tyrosine phosphorylated pro-
teins in the presence of the PP1 inhibitors reveals that
there is a general reduction in all phosphorylated proteins,
not one protein in particular. This may indicate that Fyn
 
activates another signal transduction pathway that ulti-
mately contributes to the cytoskeletal rearrangement. The
dominant negative studies confirm the hypothesis that Fyn
is essential for oligodendrocyte process formation. Identi-
fication of Fyn substrates in these cells will be necessary to
further characterize the intracellular events responsible
for the observed biology reported here.
The results obtained in this study may in part explain
the partial loss of myelin proteins in the Fyn-deficient
transgenic mice. If Fyn directs the formation of myelin
sheet formation in vivo as it does in vitro, the myelin in
these animals may show a reduction in lamellar structure,
or oligodendrocyte cell volume. This would lead to a sub-
sequent reduction in the total amount of myelin proteins.
It will be interesting to determine if the loss of myelin pro-
tein leads to a reduction of the myelin sheath formation in
Fyn-deficient mice. The initial phenotypic characterization
of the Fyn-deficient mice did not suggest a defect in myeli-
nation, as the animals exhibited normal motor function
(Stein et al., 1992, 1994). However, normal nerve conduc-
tion and motor function can be realized even if myelin
sheath is reduced to 25% of normal (Waxman, 1997,
1998). Further examination of the myelin content and the
state of oligodendrocyte differentiation from these mice
will provide more details on the role of Fyn during myeli-
nation.
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